SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Auerbach Jonathan AG – ‘SC 13G’ on 6/26/02 re: Immulogic Pharmaceutical Corp/DE

On:  Wednesday, 6/26/02, at 11:02am ET   ·   Accession #:  1176208-2-2   ·   File #:  5-41873

Previous ‘SC 13G’:  None   ·   Next:  ‘SC 13G’ on 8/10/22   ·   Latest:  ‘SC 13G/A’ on 6/5/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer

 6/26/02  Auerbach Jonathan AG              SC 13G                 1:5K   Immulogic Pharmaceutical Corp/DE

Statement of Beneficial Ownership   —   Schedule 13G
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13G      Statement of Beneficial Ownership                      3±    17K 


Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
"Item 1:. REPORTING PERSONS Jonathan A. G. Auerbach
"Item 2:. Not Applicable
"Item 4:. CITIZENSHIP United States of America
"Item 5:. Sole Voting Power 1,247,100
"Item 6:. Shared Voting Power
"Item 7:. Sole Dispositive Power -- 1,247,100
"Item 8:. Shared Dispositive Power
"Item 9:. Aggregate Amount Beneficially Owned -- 1,247,100
"Item 11:. Percent of Class Represented by Line 9 -- 6.09
"Item 12:. Type of Reporting Person -- In
"Item 1(A). Name of Issuer
"Item 1(B). Address of Issuer
"Item 2(A). Name of Person Filing
"Item 2(B). Address of Principal Business Office
"Item 2(C). Citizenship
"Item 2(D). Title of Class of Securities
"Item 2(E). Cusip Number
"Item 3. This statement is filed pursuant to Rule 13d-1 (c)
"Item 6. Ownership of More Than Five Percent on Behalf of Another Person
"Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:
"Item 8. Identification and Classification of Members of the Group
"Item 9. Notice of Dissolution of Group


Page 1 of 4 SCHEDULE 13G IMMULOGIC PHARMACEUTICALS Common Stock Cusip # 45252R100 6/18/02 Check the appropriate box to designate the rule pursuant to which the Schedule is filed: [ ] Rule 13d-1(b) [ X ] Rule 13d-1(c) [ ] Rule 13d-1(d) Page 2 of 4 Cusip # 45252R100 Item 1: REPORTING PERSONS Jonathan A. G. Auerbach Item 2: NOT APPLICABLE Item 3: NOT APPLICABLE Item 4: CITIZENSHIP United States of America Item 5: SOLE VOTING POWER 1,247,100 Item 6: SHARED VOTING POWER -- None Item 7: SOLE DISPOSITIVE POWER -- 1,247,100 Item 8: SHARED DISPOSITIVE POWER -- None Item 9: AGGREGATE AMOUNT BENEFICIALLY OWNED -- 1,247,100 Item 10: NOT APPLICABLE Item 11: PERCENT OF CLASS REPRESENTED BY LINE 9 -- 6.09 Item 12: TYPE OF REPORTING PERSON -- IN Page 3 of 4 ITEM 1(A). NAME OF ISSUER IMMULOGIC PHARMACEUTICALS ITEM 1(B). ADDRESS OF ISSUER 12 Alfred Street, Suite 300 Woburn, MA ITEM 2(A). NAME OF PERSON FILING Jonathan A. G. Auerbach ITEM 2(B). ADDRESS OF PRINCIPAL BUSINESS OFFICE 215 E 73rd Street, New York, NY 10021 ITEM 2(C). CITIZENSHIP United States of America ITEM 2(D). TITLE OF CLASS OF SECURITIES Common Stock ITEM 2(E). CUSIP NUMBER 45252R100 ITEM 3. This statement is filed pursuant to Rule 13d-1 (c). Page 4 of 4 ITEM 4. OWNERSHIP ITEM 4(a). AMOUNT BENEFICIALLY OWNED 1,247,100 ITEM 4(b). PERCENT OF CLASS 6.09 ITEM 4(c). NUMBER OF SHARE AS TO WHICH SUCH PERSON HAS: (i). SOLE POWER TO VOTE OR DIRECT THE VOTE -- 1,247,100 (ii). SHARED POWER TO VOTE OR TO DIRECT THE VOTE -- None (iii). SOLE POWER TO DISPOSE OR TO DIRECT DISPOSITION OF -- 1,247,100 (iv). SHARE POWER TO DISPOSE OR TO DIRECT DISPOSISTION OF -- None ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS If this statement is being filed to report the fact that as of 6/18/02 the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [ ] ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Not Applicable ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY: Not Applicable ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not Applicable ITEM 9. NOTICE OF DISSOLUTION OF GROUP Not Applicable ITEM 10. CERTIFICATION By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete are correct. Signature Monday, June 25, 2002 Jonathan A. G. Auerbach

Dates Referenced Herein

This ‘SC 13G’ Filing    Date    Other Filings
Filed on:6/26/02None on these Dates
6/25/02
 List all Filings 
Top
Filing Submission 0001176208-02-000002   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 10:50:56.2am ET